Amyotrophic lateral sclerosis (ALS) is a group of rare neurological diseases that mainly involve the nerve cells (neurons) responsible for controlling voluntary muscle movement.
Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral sclerosis market in these economies in the near future.
In 2017, the global Amyotrophic Lateral Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Amyotrophic Lateral Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Amyotrophic Lateral Sclerosis development in United States, Europe and China.
The key players covered in this study
Mitsubishi Tanabe Pharma
Market segment by Type, the product can be split into
Stem Cell Therapy
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Amyotrophic Lateral Sclerosis status, future forecast, growth opportunity, key market and key players.
To present the Amyotrophic Lateral Sclerosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Amyotrophic Lateral Sclerosis are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Amyotrophic Lateral Sclerosis Market Size Growth Rate by Type (2013-2025)
1.4.2 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis Market Share by Application (2013-2025)
1.5.3 Diagnostic Centres
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Amyotrophic Lateral Sclerosis Market Size
2.2 Amyotrophic Lateral Sclerosis Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis Market Size by Regions (2013-2025)
2.2.2 Amyotrophic Lateral Sclerosis Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Amyotrophic Lateral Sclerosis Market Size by Manufacturers
3.1.1 Global Amyotrophic Lateral Sclerosis Revenue by Manufacturers (2013-2018)
3.1.2 Global Amyotrophic Lateral Sclerosis Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Amyotrophic Lateral Sclerosis Market Concentration Ratio (CR5 and HHI)
3.2 Amyotrophic Lateral Sclerosis Key Players Head office and Area Served